Membranous HEG1 expression is a useful marker in the differential diagnosis of epithelioid and biphasic malignant mesothelioma versus carcinomas
暂无分享,去创建一个
Y. Miyagi | A. Marchevsky | T. Nakazawa | K. Imai | K. Hiroshima | A. Husain | Di Wu | A. Walts | Y. Sekine | S. Tsuji | T. Yusa | D. Ozaki | E. Koh
[1] Y. Miyagi,et al. HEG1, BAP1, and MTAP are useful in cytologic diagnosis of malignant mesothelioma with effusion , 2020, Diagnostic cytopathology.
[2] A. Churg,et al. HEG1 Is a Highly Specific and Sensitive Marker of Epithelioid Malignant Mesothelioma , 2020, The American journal of surgical pathology.
[3] L. Hebbard,et al. A novel function for HEG1 in promoting metastasis in hepatocellular carcinoma. , 2019, Clinical science.
[4] Yi-ming Li,et al. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling. , 2019, Clinical science.
[5] A. Churg,et al. Molecular pathways and diagnosis in malignant mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group. , 2019, Lung cancer.
[6] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[7] M. Slade,et al. British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma , 2018, Thorax.
[8] A. Gown,et al. Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group. , 2018, Archives of pathology & laboratory medicine.
[9] Y. Miyagi,et al. HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma , 2017, Scientific Reports.
[10] A. Husain,et al. BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma. , 2015, Human pathology.
[11] N. Ordóñez. Value of claudin-4 immunostaining in the diagnosis of mesothelioma. , 2013, American journal of clinical pathology.
[12] N. Ordóñez. Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas , 2013, Modern Pathology.
[13] H. Aburatani,et al. Expression and functions of transmembrane mucin MUC13 in ovarian cancer. , 2009, Cancer research.
[14] M. Lu,et al. Regulation of cardiovascular development and integrity by the Heart of Glass-Cerebral Cavernous Malformation pathway , 2009, Nature Medicine.
[15] M. Rivera,et al. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms , 2008, Modern Pathology.
[16] C. Vagianos,et al. Tight junctions in thyroid carcinogenesis: diverse expression of claudin-1, claudin-4, claudin-7 and occludin in thyroid neoplasms , 2008, Modern Pathology.
[17] B. Murer,et al. Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions , 2007, Virchows Archiv.
[18] Kyle J Hewitt,et al. The claudin gene family: expression in normal and neoplastic tissues , 2006, BMC Cancer.
[19] N. Ordóñez. Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas. , 2005, Human pathology.
[20] I. Ellis,et al. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer , 2005, Modern Pathology.
[21] M. Fishman,et al. heart of glass Regulates the Concentric Growth of the Heart in Zebrafish , 2003, Current Biology.